GHK-Cu vs NAD+ for Anti-Aging: Where the Evidence Actually Stands Neither therapy has large-scale, long-term randomized controlled trial data in humans for anti-aging endpoints specifically
Nitroglycerin can exert vasodilation in the arteries at higher doses which results in a decrease in the pressure the heart must exert (termed afterload) to expel blood from the left ventricle, thereby, adding to reduced cardiac oxygen demand
This is also where most of the controversy lies: Injections: This is the fastest-acting and most potent route, but it carries serious risks including allergic reactions, infections, kidney or thyroid damage, toxicity and ochronosis
Supplementary Figure 1 (download TIF Confirmed transcript variants of GSTA1-GSTA5
Schlich K, Terytze K, Hund-Rinke K
For laboratory research and formulation-development use only